Cited by 66Alzheimer's disease research and treatmentsUbiquitin and proteasome pathwaysDementia and Cognitive Impairment Research

Ubiquilin regulates presenilin endoproteolysis and modulates γ-secretase components, Pen-2 and nicastrin

Open access
Massey, Leann K., Mah, Alex L., Monteiro, Mervyn J.·2005·Biochemical Journal

Abstract

Mutations in presenilin proteins (PS1 and PS2) lead to early-onset Alzheimer's disease. PS proteins are endoproteolytically cleaved into two main fragments: the NTF (PS N-terminal fragment) and the CTF (PS C-terminal fragment). The two fragments are believed to constitute the core catalytic enzyme activity called γ-secretase, which is responsible for cleaving β-amyloid precursor protein to release Aβ. Thus, studying factors that modulate PS fragment levels could provide important information about γ-secretase. Previously, we demonstrated that the protein, ubiquilin-1, interacts both in vivo and in vitro with PS and that overexpression of ubiquilin-1 or -2 leads to increased accumulation of full-length PS proteins. Using wild-type HEK-293 cells (human embryonic kidney 293 cells) and PS-inducible cells, we now show that overexpression of either ubiquilin-1 or -2 decreases the PS NTF and CTF levels. Conversely, siRNA (small interfering RNA)-mediated knockdown of ubiquilin-1 and -2 proteins increased the PS NTF and CTF levels. We considered that ubiquilin might alter PS fragment accumulation by acting as a shuttle factor escorting PS fragments to the proteasome for degradation. However, through proteasome inhibition studies, we show that this does not occur. Instead, our results suggest that ubiquilin regulates PS fragment production. We also examined whether other components of the γ-secretase complex are affected by ubiquilin expression. Interestingly, overexpression of ubiquilin resulted in a decrease in Pen-2 and nicastrin levels, two essential components of the γ-secretase complex. In contrast, knockdown of ubiquilin-1 and -2 protein expression by RNAi (RNA interference) increased Pen-2 and nicastrin levels. Finally, we show that inhibition of the proteasome results in decreased PS fragment production and that reversal of proteasome inhibition restores PS fragment production, suggesting that the proteasome may be involved in PS endoproteolysis. These studies implicate ubiquilin as an important factor in regulating PS biogenesis and metabolism.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1042/bj20050491

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Presenilin ubiquitination can cause reduction of endoproteolisis, which in turn reduces the formation of two fragments (presenilin N- and C-terminal fragments) that are essential for the γ-secretase activity.

    “Moreover, there is evidence suggesting that presenilin ubiquitination can cause reduction of endoproteolisis, which in turn reduces the formation of two fragments (presenilin N- and C-terminal fragments) that are essential for the γ-secretase activity.51”
  • Presenilin proteins can be ubiquitinated.

    “In previous studies it has been shown that presenilin proteins can be ubiquitinated.51, 52”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Massey, L. K., Mah, A. L., & Monteiro, M. J.
Affiliations
University of Maryland, Baltimore (US)
Venue
Biochemical Journal
Published
2005-10-25
Volume
391
Issue
3
Pages
513-525
ISSN
  • 0264-6021 (ISSN-L)
  • 1470-8728
OpenAlex
W2038114557
Cited by
66
References
56
Citations by year
2025: 1 · 2022: 1 · 2021: 1 · 2019: 1 · 2018: 1 · 2017: 6 · 2015: 3 · 2014: 5 · 2013: 6 · 2012: 1
FWCI
5.59
Type
journal article
Language
en
Open access
Locations
  • Biochemical Journal (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute on Aging (R01AG016839, AG016839)
  • National Institute of General Medical Sciences (GM066287, R01GM066287)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
UBQLN1, UBQLN2, presenilin, gamma-secretase, Pen-2, nicastrin, proteasome, Alzheimer's disease, protein degradation, siRNA knockdown
MeSH terms
Autophagy-Related Proteins, Carrier Proteins, Cell Line, Humans, Membrane Glycoproteins, Membrane Proteins, Peptide Fragments, Endopeptidases, Ubiquitins, Gene Expression Regulation, Enzymologic, Aspartic Acid Endopeptidases, Cell Cycle Proteins, RNA Interference, Proteasome Endopeptidase Complex, Adaptor Proteins, Signal Transducing, Presenilin-1, Presenilin-2, Amyloid Precursor Protein Secretases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review